title: Diagnostic dilemmas in pulmonary hypertension.
abstract: Dilemmas persist in the screening, assessment, and follow-up of patients with pulmonary hypertension, relating to issues of whom and how to screen, how to resolve ambiguities in the clinical classification of patients with multiple potential substrates of pulmonary vascular disease, how to interpret test results, how to integrate multiple clinical parameters into a global diagnosis, how to use ambiguous test results, how to determine disease severity and prognosis, and how to monitor patients on treatment. This article describes how to incorporate available information into the diagnostic process, and where lack of concrete data should impose caution in patient management.
authors: Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA. frantz.robert@mayo.edu
authors: Robert P
authors: RP
authors: Frantz
authors: Michael D
authors: MD
authors: McGoon
mesh_terms: D015415:Biomarkers; D004417:Dyspnea; D006439:Hemodynamics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D008171:Lung Diseases; D008403:Mass Screening / Q000379:methods; D011379:Prognosis; D011651:Pulmonary Artery / Q000473:pathology; D011667:Pulmonary Veins / Q000473:pathology; D012891:Sleep Apnea Syndromes / Q000473:pathology; D016278:Ventricular Function, Right
chemical_list: D015415:Biomarkers